🚀 VC round data is live in beta, check it out!
Bruker Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bruker and similar public comparables like Convatec Group, Getinge, Bausch + Lomb, Caris Life Sciences and more.
Bruker Overview
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Founded
1991
HQ
Employees
9.7K
Website
Financials (LTM)
EV
$8B
Bruker Financials
Bruker reported last 12-month revenue of $3B and EBITDA of $576M.
In the same LTM period, Bruker generated $2B in gross profit, $576M in EBITDA, and $292M in net income.
Revenue (LTM)
Bruker P&L
In the most recent fiscal year, Bruker reported revenue of $3B and EBITDA of $535M.
Bruker expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 50% | XXX | 46% | XXX | XXX | XXX |
| EBITDA | $576M | XXX | $535M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $292M | XXX | $278M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bruker Stock Performance
Bruker has current market cap of $6B, and enterprise value of $8B.
Market Cap Evolution
Bruker's stock price is $40.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $6B | 0.0% | XXX | XXX | XXX | $1.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBruker Valuation Multiples
Bruker trades at 2.3x EV/Revenue multiple, and 13.8x EV/EBITDA.
EV / Revenue (LTM)
Bruker Financial Valuation Multiples
As of April 20, 2026, Bruker has market cap of $6B and EV of $8B.
Equity research analysts estimate Bruker's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bruker has a P/E ratio of 21.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 13.8x | XXX | 14.8x | XXX | XXX | XXX |
| EV/EBIT | 17.1x | XXX | 18.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.6x | XXX | 5.0x | XXX | XXX | XXX |
| P/E | 21.2x | XXX | 22.3x | XXX | XXX | XXX |
| EV/FCF | 72.8x | XXX | 127.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bruker Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bruker Margins & Growth Rates
Bruker's revenue in the last 12 month grew by 4%.
Bruker's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Bruker's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Bruker's rule of X is 29% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Bruker Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | 26% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 11% | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bruker Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bruker | XXX | XXX | XXX | XXX | XXX | XXX |
| Convatec Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Getinge | XXX | XXX | XXX | XXX | XXX | XXX |
| Bausch + Lomb | XXX | XXX | XXX | XXX | XXX | XXX |
| Caris Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott India | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bruker M&A Activity
Bruker acquired XXX companies to date.
Last acquisition by Bruker was on XXXXXXXX, XXXXX. Bruker acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bruker
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBruker Investment Activity
Bruker invested in XXX companies to date.
Bruker made its latest investment on XXXXXXXX, XXXXX. Bruker invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bruker
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bruker
| When was Bruker founded? | Bruker was founded in 1991. |
| Where is Bruker headquartered? | Bruker is headquartered in United States. |
| How many employees does Bruker have? | As of today, Bruker has over 9K employees. |
| Who is the CEO of Bruker? | Bruker's CEO is Frank H. Laukien. |
| Is Bruker publicly listed? | Yes, Bruker is a public company listed on Nasdaq. |
| What is the stock symbol of Bruker? | Bruker trades under BRKR ticker. |
| When did Bruker go public? | Bruker went public in 2000. |
| Who are competitors of Bruker? | Bruker main competitors are Convatec Group, Getinge, Bausch + Lomb, Caris Life Sciences. |
| What is the current market cap of Bruker? | Bruker's current market cap is $6B. |
| What is the current revenue of Bruker? | Bruker's last 12 months revenue is $3B. |
| What is the current revenue growth of Bruker? | Bruker revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Bruker? | Current revenue multiple of Bruker is 2.3x. |
| Is Bruker profitable? | Yes, Bruker is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Bruker? | Bruker's last 12 months EBITDA is $576M. |
| What is Bruker's EBITDA margin? | Bruker's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Bruker? | Current EBITDA multiple of Bruker is 13.8x. |
| What is the current FCF of Bruker? | Bruker's last 12 months FCF is $109M. |
| What is Bruker's FCF margin? | Bruker's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Bruker? | Current FCF multiple of Bruker is 72.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.